Grace Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $0.00.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $4.28M.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $0.00.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2026 was $4.28M.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $0.00.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2023 was $304.00K.
- Grace Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $59.34M, a 754.86% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.28M 10-K · filed 2026-06-18 | |
| 2025-12-31 | $4.28M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $0.00 10-Q · filed 2026-02-12 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-K · filed 2026-06-18 | |
| 2024-06-30 | $0.00 10-Q · filed 2026-02-12 | |
| 2023-03-31 | $304.00K 10-K · filed 2024-06-21 | |
| 2022-09-30 | $109.00K 10-Q · filed 2024-02-12 | |
| 2022-06-30 | $195.00K 10-Q · filed 2024-02-12 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $59.34M 10-K · filed 2022-06-21 | |
| 2020-12-31 | $19.63M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $3.43M 10-Q · filed 2022-02-14 | |
| 2020-06-30 | $1.76M 10-Q · filed 2022-02-14 | |
| 2020-03-31 | $6.94M 10-K · filed 2021-06-22 | |
| 2019-12-31 | $6.00M 10-Q · filed 2021-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |